Trials / Completed
CompletedNCT02237079
Bazedoxifene/Conjugated Estrogens (BZA/CE) Improvement of Metabolism (BIM)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Tulane University Health Sciences Center · Academic / Other
- Sex
- Female
- Age
- 50 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this pilot clinical study is to perform a randomized placebo-controlled study to assess the beneficial effect of a 3 month-treatment with Bazedoxifene/Conjugated Estrogens (BZA/CE) vs. placebo on glucose homeostasis and body composition in 20 post-menopausal women. The recruitment will be performed at Tulane Health Sciences Center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bazedoxifene/Conjugated Estrogens (BZA/CE) | Daily tablet containing conjugated estrogens 0.45 mg and bazedoxifene 20 mg. |
| DRUG | Placebo Oral Tablet | Daily placebo tablet |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2014-09-11
- Last updated
- 2023-06-26
- Results posted
- 2023-06-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02237079. Inclusion in this directory is not an endorsement.